Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lindberg, Karolina ^a   Olauson, Hannes ^a   Amin, Risul ^a   Ponnusamy, Arvind ^b   Goetz, Regina ^c   Taylor, Rebecca F ^b   Mohammadi, Moosa ^c   Canfield, Ann ^b   Kublickiene, Karolina ^a   Larsson, Tobias E ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CREATININE; EARLY GROWTH RESPONSE FACTOR 1; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTERY CALCIFICATION; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FEMORAL ARTERY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG ARTERY; MALE; MESENTERIC ARTERY; MINERAL METABOLISM; MOUSE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; ARTERIES; CALCINOSIS; CATTLE; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; FIBROBLAST GROWTH FACTORS; GENE DELETION; GENE EXPRESSION REGULATION; GLUCURONIDASE; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; TIME FACTORS;

BOVINAE; MURINAE; MUS;

EID: 84875948898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060658     Document Type: Article

References (22)

1. Foley RN, Parfrey PS, Sarnak MJ, (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-119.
2. Mirza MA, Hansen T, Johansson L, Ahlstrom H, Larsson A, et al. (2009) Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant 24: 3125-3131.
3. Mirza MA, Larsson A, Lind L, Larsson TE, (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205: 385-390.
4. Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE, (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis.
5. Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, et al. (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119: 2545-2552.
6. Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, et al. (2012) Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol 60: 200-207.
7. Arnlov J, Carlsson AC, Sundstrom J, Ingelsson E, Larsson A, et al. (2012) Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community. Kidney Int.
8. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774.
9. Wolf M, (2010) Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21: 1427-1435.
10. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, et al. (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408.
11. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, et al. (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22: 124-136.
12. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, et al. (2012) Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125: 2243-2255.
13. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, et al. (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A 99: 7142-7147.
14. Olauson H, Lindberg K, Amin R, Jia T, Wernerson A, et al. (2012) Targeted deletion of klotho in kidney distal tubule disrupts mineral metabolism. J Am Soc Nephrol 23: 1641-1651.
15. Alam MU, Kirton JP, Wilkinson FL, Towers E, Sinha S, et al. (2009) Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 81: 260-268.
16. Collett GD, Sage AP, Kirton JP, Alexander MY, Gilmore AP, et al. (2007) Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. Circ Res 100: 502-509.
17. Siddals KW, Allen J, Sinha S, Canfield AE, Kalra PA, et al. (2011) Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. J Biol Chem 286: 16623-16630.
18. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592.
19. Donate-Correa J, Mora-Fernandez C, Martinez-Sanz R, Muros-de-Fuentes M, Perez H, et al. (2011) Expression of FGF23/KLOTHO system in human vascular tissue. Int J Cardiol.
20. Kato Y, Arakawa E, Kinoshita S, Shirai A, Furuya A, et al. (2000) Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem Biophys Res Commun 267: 597-602.
21. Shalhoub V, Shatzen EM, Ward SC, Davis J, Stevens J, et al. (2012) FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 122: 2543-2553.
22. Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, et al. (2010) Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A 107: 407-412.